Human Sulfotransferases and Their Role in Chemical Metabolism
The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Abstract
Sulfonation is an important reaction in the metabolism of numerous xenobiotics, drugs, and endogenous compounds. A supergene family of enzymes called sulfotransferases (SULTs) catalyze this reaction. In most cases, the addition of a sulfonate moiety to a compound increases its water solubility and decreases its biological activity. However, many of these enzymes are also capable of bioactivating procarcinogens to reactive electrophiles. In humans three SULT families, SULT1, SULT2, and SULT4, have been identified that contain at least thirteen distinct members. SULTs have a wide tissue distribution and act as a major detoxification enzyme system in adult and the developing human fetus. Nine crystal structures of human cytosolic SULTs have now been determined, and together with site-directed mutagenesis experiments and molecular modeling, we are now beginning to understand the factors that govern distinct but overlapping substrate specificities. These studies have also provided insight into the enzyme kinetics and inhibition characteristics of these enzymes. The regulation of human SULTs remains as one of the least explored areas of research in the field, though there have been some recent advances on the molecular transcription mechanism controlling the individual SULT promoters. Interindividual variation in sulfonation capacity may be important in determining an individual's response to xenobiotics, and recent studies have begun to suggest roles for SULT polymorphism in disease susceptibility. This review aims to provide a summary of our present understanding of the function of human cytosolic sulfotransferases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This represents a very large diversification in these gene families relative to those in mammals: the human genome contains 13 SULT, 13 UGT and 17 GST genes”
From The chemical defensome: Environmental sensing and response genes in the Strongylocentrotus purpuratus genome (2006) · cites this paper as Gamage et al., 2006
In the citing paper
“p-cresol and acetaminophen are both substrates of the human cytosolic sulfotransferase SULT1A181 (Fig. 3). This competition likely impedes the host’s ability to detoxify acetaminophen, increasing the likelihood of accumulating the toxic metabolite NAPQI.”
From The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism (2016) · cites this paper as [81]
Citations
Cites
Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences
Mammalian Gene Collection (MGC) Program Team* (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242603899 · Cited by 1,749
Carcinogenesis by chemicals: an overview--G. H. A. Clowes memorial lecture.
MILLER, J. A. (1970) · PubMed · Cited by 1,450
Enzymology of human cytosolic sulfotransferases
Falany, C. N. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.4.9068609 · Cited by 604 · cited 6×
“…for xenobiotics such as N-hydroxy arylamines, N-hydroxy heterocyclic amines and hydroxymethyl polycyclic aromatic hydrocarbons, sulfonation is a metabolic activation process leading to highly reactive electrophiles that are both mutagenic and carcinogenic (Falany, 1997; Weinshilboum et al. 1997).”
BackgroundInfluentialMonroy-Noyola, A., Sogorb, M. A., Dı́az-Alejo, N., Ñı́guez, N., Barril, J., Vicedo, J. L., Escudero, M. A., & Vilanova, E. (1999) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(99)00035-6 · Cited by 531
Maglich, J. M., Parks, D. J., Moore, L. B., Collins, J. L., Goodwin, B., Billin, A. N., Stoltz, C. A., Kliewer, S. A., Lambert, M. H., Willson, T. M., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300138200 · Cited by 416 · cited 1×
“One study describes 11-fold induction of SULT1A1 mRNA after treatment of primary human hepatocytes with the human CAR ligand 6-(4-Chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehydeO-(3,4-dichlorobenzyl) oxime [Citco; (Maglich et al. 2003)].”
MethodSulfation and sulfotransferases 1: Sulfotransferase molecular biology: cDNAs and genes.
Weinshilboum, R. M., Otterness, D. M., Aksoy, I. A., Wood, T. C., Her, C., & Raftogianis, R. B. (1997) · PubMed · Cited by 408
Sulfotransferase molecular biology: cDNAs and genes
Weinshilboum, R. M., Otterness, D. M., Aksoy, I. A., Wood, T. C., Her, C., & Raftogianis, R. B. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.1.9034160 · Cited by 369 · cited 2×
“For a drug like acetaminophen or a neurotransmitter such as dopamine, this is certainly the case; however, for xenobiotics such as N-hydroxy arylamines, Nhydroxy heterocyclic amines, and hydroxymethyl polycyclic aromatic hydrocarbons, sulfonation is a metabolic activation process leading to highly reactive electrophil…”
BackgroundThe importance of 3‘‐phosphoadenosine 5‘‐phosphosulfate (PAPS) in the regulation of sulfation
Klaassen, C. D., & Boles, J. W. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.6.9194521 · Cited by 357 · cited 1×
“The importance of PAPS in the regulation of sulfonation has been expertly reviewed (Klaassen and Boles, 1997; Schwartz, 2005).”
BackgroundSulfotransferases in the bioactivation of xenobiotics
Glatt, H. (2000) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(00)00202-7 · Cited by 354 · cited 8×
“This could, at least in part, explain the lowered activation of this compound observed with SULT1A3 (Glatt, 2000).”
BackgroundResultInfluentialStructure and Function of Sulfotransferases
Negishi, M., Pedersen, L. G., Petrotchenko, E., Shevtsov, S., Gorokhov, A., Kakuta, Y., & Pedersen, L. C. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2368 · Cited by 333 · cited 2×
“, CCK), proteins, lipids, and glycosaminoglycans, affecting both their structural and functional characteristics (Falany, 1997; Negishi et al., 2001) and (2) cytosolic SULTs that are responsible for the metabolism of xenobiotics and small endogenous substrates such as steroids, bile acids, and neurotransmitters.”
Background
Cited by
Correlating chemical sensitivity and basal gene expression reveals mechanism of action
Rees, M. G., Seashore-Ludlow, B., Cheah, J. H., Adams, D. J., Price, E. V., Gill, S., Javaid, S., Coletti, M. E., Jones, V. L., Bodycombe, N. E., et al. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.1986 · Cited by 898
Clayton, T. A., Baker, D., Lindon, J. C., Everett, J. R., & Nicholson, J. K. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904489106 · Cited by 765
“There are various human sulfotransferases (both cytosolic and membrane-bound), but human cytosolic sulfotransferase SULT1A1, which acts on acetaminophen, has a broad substrate range and is one of the most important sulfotransferases for xenobiotic sulfonation as well as acting on several endogenous substrates (26, 51).”
BackgroundInfluentialMechanisms of Multidrug Resistance in Cancer
Gillet, J.-P., & Gottesman, M. M. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-416-6_4 · Cited by 685
The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism
Spanogiannopoulos, P., Bess, E. N., Carmody, R. N., & Turnbaugh, P. J. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.17 · Cited by 717
PHASE II DRUG METABOLIZING ENZYMES
Jancova, P., Anzenbacher, P., & Anzenbacherova, E. (2010) · Biomedical Papers · doi:10.5507/bp.2010.017 · Cited by 603
Kapetanovic, I. M., Muzzio, M., Huang, Z., Thompson, T. N., & McCormick, D. L. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-010-1525-4 · Cited by 609
“The gastrointestinal tract, liver, and kidneys possess high levels of Phase II metabolizing activities [14, 39]; resveratrol has been reported to undergo rapid and extensive glucuronidation and sulfation, and the gastrointestinal tract may be the major site for its metabolism [13, 19].”
BackgroundShimada, T. (2006) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.21.257 · Cited by 606
Westerink, W. M. A., & Schoonen, W. G. E. J. (2007) · Toxicology in Vitro · doi:10.1016/j.tiv.2007.05.014 · Cited by 544
Functions of Gut Microbiota Metabolites, Current Status and Future Perspectives
Liu, J., Tan, Y., Cheng, H., Zhang, D., Feng, W., & Peng, C. (2022) · Aging and disease · doi:10.14336/ad.2022.0104 · Cited by 529
“This competition hampers the capability of liver to reduce the toxicity of acetaminophen [196].”
BackgroundA gut-derived metabolite alters brain activity and anxiety behaviour in mice
Needham, B. D., Funabashi, M., Adame, M. D., Wang, Z., Boktor, J. C., Haney, J., Wu, W.-L., Rabut, C., Ladinsky, M. S., Hwang, S.-J., et al. (2022) · Nature · doi:10.1038/s41586-022-04396-8 · Cited by 489
Anthraquinones As Pharmacological Tools and Drugs
Malik, E. M., & Müller, C. E. (2016) · Medicinal Research Reviews · doi:10.1002/med.21391 · Cited by 448
Liu, X., Ji, K., & Choi, K. (2012) · Aquatic Toxicology · doi:10.1016/j.aquatox.2012.02.019 · Cited by 441
Lim, Y. J., Sidor, N. A., Tonial, N. C., Che, A., & Urquhart, B. L. (2021) · Toxins · doi:10.3390/toxins13020142 · Cited by 373
“P-cresol is absorbed and subsequently sulfated in the liver by SULT1A1 to produce p-cresyl sulfate (pCS) [48] (Figure 1).”
BackgroundRiches, Z., Stanley, E. L., Bloomer, J. C., & Coughtrie, M. W. H. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.028399 · Cited by 365
“…of xenobiotics, including many drugs, dietary chemicals, and environmental pollutants, and for the biosynthesis and homeostasis of essential endogenous compounds such as steroid/thyroid hormones and catecholamines (Coughtrie, 2002; Strott, 2002; Blanchard et al., 2004; Gamage et al., 2006).”
BackgroundCoordinate regulation of Phase I and II xenobiotic metabolisms by the Ah receptor and Nrf2
Köhle, C., & Bock, K. W. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.01.009 · Cited by 342
Critical evaluation of key evidence on the human health hazards of exposure to bisphenol A
Hengstler, J. G., Foth, H., Gebel, T., Kramer, P.-J., Lilienblum, W., Schweinfurth, H., Völkel, W., Wollin, K.-M., & Gundert-Remy, U. (2011) · Critical Reviews in Toxicology · doi:10.3109/10408444.2011.558487 · Cited by 346
“Likewise, SULT1E1 and SULT2A1, which are also capable of BPA sulfation, have also been detected and investigated in fetal tissues (Coughtrie, 2002; Gamage et al., 2006; Pacifici and Marchi, 1993; Duanmu et al., 2006; Miki et al., 2002; Stanley et al., 2005).”
BackgroundThe gut microbiome: an orchestrator of xenobiotic metabolism
Collins, S. L., & Patterson, A. D. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.12.001 · Cited by 348
Turesky, R. J., & Le Marchand, L. (2011) · Chemical Research in Toxicology · doi:10.1021/tx200135s · Cited by 337
The influence of gut microbiota on drug metabolism and toxicity
Li, H., He, J., & Jia, W. (2016) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2016.1121234 · Cited by 278
“Since p-cresol and acetaminophen are competitive substrates for cytosolic sulfotransferase,[51] the high level of p-cresol may compete with acetaminophen for binding with cytosolic sulfotransferase, and consequently alters the bioavailability of acetaminophen and its metabolites, leading to the individual variation in…”
BackgroundGoldstone, J. V., Hamdoun, A., Cole, B. J., Howard-Ashby, M., Nebert, D. W., Scally, M., Dean, M., Epel, D., Hahn, M. E., & Stegeman, J. J. (2006) · Developmental Biology · doi:10.1016/j.ydbio.2006.08.066 · Cited by 280
“This represents a very large diversification in these gene families relative to those in mammals: the human genome contains 13 SULT, 13 UGT and 17 GST genes (Gamage et al., 2006; Mackenzie et al., 2005; Nebert and Vasiliou, 2004; Pearson, 2005).”
BackgroundInfluentialThe Uremic Retention Solute p-Cresyl Sulfate and Markers of Endothelial Damage
Meijers, B. K. I., Van kerckhoven, S., Verbeke, K., Dehaen, W., Vanrenterghem, Y., Hoylaerts, M. F., & Evenepoel, P. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.04.022 · Cited by 242
Bioavailability challenges associated with development of anti-cancer phenolics
Gao, S., & Hu, M. (2010) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955710791384081 · Cited by 242
Structural and Chemical Profiling of the Human Cytosolic Sulfotransferases
Allali-Hassani, A., Pan, P. W., Dombrovski, L., Najmanovich, R., Tempel, W., Dong, A., Loppnau, P., Martin, F., Thonton, J., Edwards, A. M., et al. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050097 · Cited by 217
“Based on these observations and considering possible substrate inhibition [19,43], we tested all sulfotransferases at substrate concentrations of 10, 25, and 100 lM.”
BackgroundWesterink, W. M. A., & Schoonen, W. G. E. J. (2007) · Toxicology in Vitro · doi:10.1016/j.tiv.2007.06.017 · Cited by 226
From pregnancy to preeclampsia: a key role for estrogens
Berkane, N., Liere, P., Oudinet, J.-P., Hertig, A., Lefèvre, G., Pluchino, N., Schumacher, M., & Chabbert-Buffet, N. (2017) · Endocrine Reviews · doi:10.1210/er.2016-1065 · Cited by 223
The role of drug metabolizing enzymes in clearance
Di, L. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.876006 · Cited by 206
“In human, four SULT families (SULT1, SULT2, SULT4, SULT6) have been identified containing at least 13 distinct members (Table 5) [94,96].”
BackgroundThe structural biology of oestrogen metabolism
Thomas, M. P., & Potter, B. V. L. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2012.12.014 · Cited by 182
Developing a metagenomic view of xenobiotic metabolism
Haiser, H. J., & Turnbaugh, P. J. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2012.07.009 · Cited by 186
“p-Cresol is an amino acid derivative that, like acetaminophen, is a substrate for hepatic sulfotransferase enzymes [90].”
BackgroundHuman liver-kidney model elucidates the mechanisms of aristolochic acid nephrotoxicity
Chang, S.-Y., Weber, E. J., Sidorenko, V. S., Chapron, A., Yeung, C. K., Gao, C., Mao, Q., Shen, D., Wang, J., Rosenquist, T. A., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.95978 · Cited by 179
Toxicokinetics of Tetrabromobisphenol A in Humans and Rats after Oral Administration
Schauer, U. M. D., Völkel, W., & Dekant, W. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfj132 · Cited by 163
“A number of sulfotransferases are polymorphic in humans (Gamage et al., 2006; Glatt and Meinl, 2004).”
BackgroundKöhle, C., & Bock, K. W. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.05.020 · Cited by 157
A light-dependent molecular link between competition cues and defence responses in plants
Fernández-Milmanda, G. L., Crocco, C. D., Reichelt, M., Mazza, C. A. D. S., Köllner, T. G., Zhang, T., Cargnel, M. D., Lichy, M. Z., Fiorucci, A.-S., Fankhauser, C., et al. (2020) · Nature Plants · doi:10.1038/s41477-020-0604-8 · Cited by 154
Mechanisms underlying food–drug interactions: Inhibition of intestinal metabolism and transport
Won, C. S., Oberlies, N. H., & Paine, M. F. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.08.001 · Cited by 170
“Three human SULT subfamilies have been identified and detected in liver, brain, intestine, lung, kidney, and other tissues (Gamage et al., 2006).”
BackgroundFunction and organization of the human cytosolic sulfotransferase (SULT) family
Coughtrie, M. W. H. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2016.05.005 · Cited by 142
“These biotransformation reactions are catalyzed by members of the cytosolic sulfotransferase (SULT) superfamily [3,8], all of which utilize the universal sulfuryl donor 30-phosphoadenosine 50-phosphosulfate (PAPS) [9] in the transfer of SO3 to acceptor substrates through hydroxyl or amino functions.”
Milan, M., Coppe, A., Reinhardt, R., Cancela, M. L., Leite, R. B., Saavedra, C., Ciofi, C., Chelazzi, G., Patarnello, T., Bortoluzzi, S., et al. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-234 · Cited by 142
N-glucuronidation of drugs and other xenobiotics by human and animal UDP-glucuronosyltransferases
Kaivosaari, S., Finel, M., & Koskinen, M. (2011) · Xenobiotica · doi:10.3109/00498254.2011.563327 · Cited by 140
“The two main phase II reactions are glucuronidation, which is catalyzed by the uridine diphosphate (UDP) glucuronosyltransferases (UGTs; Burchell and Coughtrie 1989; Clarke and Burchell 1994; Tukey and Strassburg 2000), and sulfonation that is catalyzed by the sulfotransferase enzymes (Coughtrie et al. 2002; Gamage et…”
BackgroundXu, Z., Gan, L., Li, T., Xu, C., Chen, K., Wang, X., Qin, J. G., Chen, L., & Li, E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136506 · Cited by 149
“These findings could provide new research directions for studying DHEA in aquatic animals.”
BackgroundInfluentialTriclosan is a potent inhibitor of estradiol and estrone sulfonation in sheep placenta
James, M. O., Li, W., Summerlot, D. P., Rowland‐Faux, L., & Wood, C. E. (2009) · Environment International · doi:10.1016/j.envint.2009.02.004 · Cited by 137
“The small uncompetitive component of inhibition may be analogous to the described mechanism of partial substrate inhibition, in which a second molecule of substrate (or inhibitor) binds to the enzyme-substrate complex and partially inhibits product formation (Gamage et al., 2006; Zhang et al., 1998).”
Guertin, K. A., Loftfield, E., Boca, S. M., Sampson, J. N., Moore, S. C., Xiao, Q., Huang, W.-Y., Xiong, X., Freedman, N. D., Cross, A. J., et al. (2015) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.096099 · Cited by 134
Hardwick, R. N., Ferreira, D. W., More, V. R., Lake, A. D., Lu, Z. J., Manautou, J. E., Slitt, A. L., & Cherrington, N. J. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.048439 · Cited by 134
“…two prominent classes of phase II enzymes because they transform a large proportion of drugs and endogenous molecules, including bilirubin, steroid hormones, bile acids, eicosanoids, and neurotransmitters (Gamage et al., 2006; Zamek-Gliszczynski et al., 2006; Bock, 2010; Jancova et al., 2010).”
BackgroundInfluentialTargeting gut microbiota for precision medicine: Focusing on the efficacy and toxicity of drugs
Feng, W., Liu, J., Ao, H., Yue, S., & Peng, C. Y. (2020) · Theranostics · doi:10.7150/thno.47289 · Cited by 140
“In the liver, p-cresol is metabolized to p-cresol sulfate, a substrate of the human cytosolic sulfotransferase 1A1 (SULT1A1), which is shared by acetaminophen [76].”
Backgroundvan der Deure, W. M., Peeters, R. P., & Visser, T. J. (2010) · Journal of Molecular Endocrinology · doi:10.1677/jme-09-0042 · Cited by 130
“Serum E1S is a major source of estrogens for breast tissue through local sulfatase activity (Gamage et al. 2006).”
van de Wetering, K., Burkon, A., Feddema, W., Bot, A. G. M., de Jonge, H. R., Somoza, V., & Borst, P. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.052019 · Cited by 138
“Liver, kidney, and the gastrointestinal tract are organs with a high phase II-metabolizing activity (Tukey and Strassburg, 2000; Gamage et al., 2006).”
BackgroundFrench, J. E., Gatti, D. M., Morgan, D. L., Kissling, G. E., Shockley, K. R., Knudsen, G. A., Shepard, K. G., Price, H. C., King, D., Witt, K. L., et al. (2014) · Environmental Health Perspectives · doi:10.1289/ehp.1408202 · Cited by 130
Regulation of coenzyme A levels by degradation: the ‘Ins and Outs’
Naquet, P., Kerr, E. W., Vickers, S. D., & Leonardi, R. (2020) · Progress in Lipid Research · doi:10.1016/j.plipres.2020.101028 · Cited by 128
“also produced by sulfotransferases, enzymes that transfer a sulfonic group from 3’phosphoadenosyl-5’-phosphosulfate to an acceptor molecule [173, 174], and during the transfer of the PPanSH prosthetic group from CoA to proteins such as the mitochondrial acyl carrier protein and the eukaryotic fatty acid synthase [175,…”
BackgroundHirschmann, F., Krause, F., & Papenbrock, J. (2014) · Frontiers in Plant Science · doi:10.3389/fpls.2014.00556 · Cited by 132
“Furthermore, it was strongly induced by salt and sorbitol and slightly by cold, ABA, auxins, cytokinins, methyl jasmonate, salicylic acid, and interactions with bacterial pathogens (Lacomme and Roby, 1996; Baek et al., 2010).”
BackgroundInfluentialNies, A. T., Schwab, M. G., & KEPPLER, D. O. R. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.5.545 · Cited by 122
“Anionic conjugates are formed either inside the hepatocytes or extrahepatically, typically by the action of UDP-glycosyltransferases (UGTs) [20,21] , sulfotransferases (SULTs) [22,23] , and glutathione S -transferases (GSTs), ( Figure 2 ) [24] .”
BackgroundYe, H., Ha, M., Yang, M. H., Yue, P., Xie, Z., & Liu, C. (2017) · Scientific Reports · doi:10.1038/srep40153 · Cited by 122
Dänicke, S., & Winkler, J. (2015) · Food and Chemical Toxicology · doi:10.1016/j.fct.2015.08.009 · Cited by 131
Foti, R., & Dalvie, D. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.071753 · Cited by 120
“and decreased pharmacological activity, a number of reports of sulfotransferase-catalyzed bioactivation have been noted, as in the case of 3-n-butylphthalide (Chou et al., 1995a,b, 1998; Gamage et al., 2006; Diao et al., 2014).”
MethodDänicke, S., & Brezina, U. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.07.017 · Cited by 116
Campbell, A. S., Needham, B. D., Meyer, C. R., Tan, J. H. J., Conrad, M. C., Preston, G. M., Bolognani, F., Rao, S. G., Heussler, H., Griffith, R., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01683-9 · Cited by 120
Chen, X., Jia, W. P., Zhu, L., Mao, L., & Zhang, Y. (2019) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12511 · Cited by 111
Updated perspectives on the cytosolic sulfotransferases (SULTs) and SULT-mediated sulfation
Suiko, M., Kurogi, K., Hashiguchi, T., Sakakibara, Y., & Liu, M. (2016) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2016.1222266 · Cited by 110
Zhang, Y., Chen, X., & Zhang, Y. (2021) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12705 · Cited by 108
Goldstone, J. V. (2008) · Cell Biology and Toxicology · doi:10.1007/s10565-008-9107-5 · Cited by 112
“…and UGT enzymes catalyze the conjugation of sulfuryl groups donated by 3′-phosphoadenosine5′-phosphosulfate or UDP-glucuronide, respectively, to a wide variety of substrates, including both xenobiotics and endogenous products (Bock and Kohle 2004; Gamage et al. 2006; Runge-Morris and Kocarek 2005).”
InfluentialSecondary sulfur metabolism in cellular signalling and oxidative stress responses
Chan, K. X., Phua, S. Y., & Breusegem, F. V. (2019) · Journal of Experimental Botany · doi:10.1093/jxb/erz119 · Cited by 121
Tu, Y., Liu, S., Cai, P., & Shan, T. (2023) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.13203 · Cited by 103
Gosavi, R. A., Knudsen, G. A., Birnbaum, L. S., & Pedersen, L. C. (2013) · Environmental Health Perspectives · doi:10.1289/ehp.1306902 · Cited by 99
“Environmental Health Perspectives • volume 121 | number 10 | October 2013 1195 (Gamage et al. 2006; Song 2001; Wang and James 2006).”
BackgroundThe important roles of steroid sulfatase and sulfotransferases in gynecological diseases
Rižner, T. L. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00030 · Cited by 98
“Finally, the reaction products, PAP and E1-S are released, which completes the catalytic cycle (Gamage et al., 2006; Tibbs et al., 2015) (Figure 3B).”
BackgroundJiang, W., & Hu, M. (2012) · RSC Advances · doi:10.1039/c2ra01369j · Cited by 97
Protein Profiles in Zebrafish (Danio rerio) Embryos Exposed to Perfluorooctane Sulfonate
Shi, X., Yeung, L. W. Y., Lam, P. K. S., Wu, R. S. S., & Zhou, B. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp111 · Cited by 101
“They are involved in the biotransformation of endogenous chemicals such as steroid/ thyroid hormones and in the detoxification of environmental xenobiotics in animals (Gamage et al., 2006).”
BackgroundA Perspective: Active Role of Lipids in Neurotransmitter Dynamics
Postila, P. A., & Róg, T. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01775-7 · Cited by 98
Mechanisms of gastrointestinal microflora on drug metabolism in clinical practice
Sun, C., Chen, L., & Shen, Z. (2019) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2019.09.011 · Cited by 97
“As p-cresol and acetaminophen are both substrates for cytosolic sulfotransferases (Gamage et al., 2006), high baseline p-cresol produced by Clostridium difficile and others competes with acetaminophen for binding with the enzyme, leading to changes in the bioavailability of acetaminophen and its metabolites.”
Cometabolism of Microbes and Host: Implications for Drug Metabolism and Drug-Induced Toxicity
Li, H., & Jia, W. P. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.157 · Cited by 94
The impact of SO2 on wine flavanols and indoles in relation to wine style and age
Arapitsas, P., Guella, G., & Mattivi, F. (2018) · Scientific Reports · doi:10.1038/s41598-018-19185-5 · Cited by 91
Aldehyde oxidase and its role as a drug metabolizing enzyme
Dalvie, D., & Di, L. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.05.011 · Cited by 95
Characterization of Differential Tissue Abundance of Major Non-CYP Enzymes in Human
Basit, A., Neradugomma, N. K., Wolford, C. C., Fan, P. W., Murray, B. P., Takahashi, R., Khojasteh, S. C., Smith, B. J., Heyward, S. A., Totah, R. A., et al. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00559 · Cited by 92
Regulation of the cytosolic sulfotransferases by nuclear receptors
Runge‐Morris, M., Kocarek, T. A., & Falany, C. N. (2013) · Drug Metabolism Reviews · doi:10.3109/03602532.2012.748794 · Cited by 91
“The SULTs are widely expressed in hepatic tissue and in metabolically active or hormonally responsive extrahepatic tissues (Dooley et al., 2000; Gamage et al., 2006).”
BackgroundChen, Y., Jin, S., Zhang, M., Hu, Y., Wu, K.-L., Chung, A., Wang, S., Tian, Z., Wang, Y., Wolynes, P. G., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33111-4 · Cited by 90
Rittié, L., Kang, S., Voorhees, J. J., & Fisher, G. J. (2008) · Archives of Dermatology · doi:10.1001/archderm.144.9.1129 · Cited by 90
A new perspective on the importance of glycine conjugation in the metabolism of aromatic acids
Badenhorst, C. P. S., Erasmus, E., van der Sluis, R., Nortjé, C., & van Dijk, A. A. (2014) · Drug Metabolism Reviews · doi:10.3109/03602532.2014.908903 · Cited by 103
“reactions are still the subject of much research in pharmacology and toxicology because of their impact on metabolism and predisposition to adverse drug responses (Gamage et al., 2006; Guillemette, 2003; Ritter, 2000; Rodriguez-Antona et al., 2010).”
BackgroundPaxton, J. W. (2012) · InTech eBooks · doi:10.5772/1180 · Cited by 96
Dash, R., Ali, M. C., Dash, N., Azad, M. A. K., Hosen, S. M. Z., Hannan, M. A., & Moon, I. S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246256 · Cited by 88
“The catalytic activity of SULT1A1 depends on the Glu83, Asp134, Glu246, and Asp263 residues [2,34].”
BackgroundInfluentialBiotransformation and bioactivation reactions of alicyclic amines in drug molecules
Bolleddula, J., DeMent, K., Driscoll, J. P., Worboys, P. D., Brassil, P. J., & Bourdet, D. L. (2014) · Drug Metabolism Reviews · doi:10.3109/03602532.2014.924962 · Cited by 93
“Other phase 2 reactions such as N-sulfate and N-acetyl conjugation are commonly observed metabolic pathways for aromatic and aliphatic heterocylic amines (Gamage et al., 2006).”
BackgroundCaballero, J., Frenette, G., & Sullivan, R. (2010) · Veterinary Medicine International · doi:10.4061/2011/757194 · Cited by 103
“Estrogen sulfotransferase (EST) is a cytosolic enzyme that catalyzes a specific sulfonation with high substrate affinity for estrogens (estrone and estradiol) [111].”
BackgroundComparative metabolism of tramadol and tapentadol: a toxicological perspective
Barbosa, J., Faria, J., Queirós, O., Moreira, R. F., Carvalho, F. D., & Dinis‐Oliveira, R. J. (2016) · Drug Metabolism Reviews · doi:10.1080/03602532.2016.1229788 · Cited by 81
“Additionally, heterogeneity in SULT families among different animal species has made extrapolation of the results more difficult (Gamage et al., 2006; Jancova et al., 2010).”
BackgroundInfluentialXenobiotica-metabolizing enzymes in the lung of experimental animals, man and in human lung models
Oesch, F., Fabian, E. J., & Landsiedel, R. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02602-7 · Cited by 85
Kuuranne, T., Leinonen, A., Schänzer, W., Kamber, M., Kostiainen, R. K., & Thevis, M. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.017954 · Cited by 80
“Features such as product and substrate inhibition have been reported especially characteristic for sulfotransferases (Chapman et al., 2004; Gamage et al., 2006), and these parameters should be optimized in detail when the interest of the assay is in the synthesis of a specific metabolite.”
BackgroundOng, V. S., Flanagan, S. D., Fang, E., Dreskin, H. J., Locke, J. B., Bartizal, K. F., & Prokocimer, P. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.056697 · Cited by 80
“…catalyzed by a family of sulfotransferases (SULTs) located in the cytosol (for metabolism of xenobiotics and small endogenous substrates) or bound to the Golgi apparatus (responsible for sulfonation of peptides, proteins, lipids, and glycosaminoglycans) (Gamage et al., 2006; Lindsay et al., 2008).”
BackgroundInfluentialNegreira, N., Erratico, C., Kosjek, T., van Nuijs, A. L. N., Heath, E., Neels, H. M., & Covaci, A. (2015) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-015-8763-6 · Cited by 79
Roques, B. B., Lacroix, M. Z., Puel, S., Gayrard, V., Picard‐Hagen, N., Jouanin, I., Perdu-Durand, E., Martin, P. G. P., & Viguié, C. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs094 · Cited by 85
“This enzyme activity can be considered as a relevant index for the capacity of the liver to sulfoconjugate thyroid hormones as both the sulfoconjugation of thyroid hormones and 2-naphthol are carried out by phenol sulfotransferases (Gamage et al., 2006).”
BackgroundPrueksaritanont, T., Lin, J. H., & Baillie, T. A. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.08.009 · Cited by 78
Suominen, T., Uutela, P., Ketola, R. A., Bergquist, J., Hillered, L., Finel, M., Zhang, H., Laakso, A., & Kostiainen, R. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068007 · Cited by 83
“Both DA and 5-HT, and their respective metabolites, can undergo conjugation with glucuronic acid or sulfonate mediated by catalysis with UDP-glucuronosyltransferases (UGTs) and sulfo- transferases (SULTs), respectively.”
BackgroundInfluentialSubstrate inhibition kinetics in drug metabolism reactions
Wu, B. (2011) · Drug Metabolism Reviews · doi:10.3109/03602532.2011.615320 · Cited by 78
“This builds up a partial negative charge on the bridging oxygen of PAPS, which alters the electrostatic equilibrium of the lysine from interacting with the serine to interacting with the 5′-phosphate, thereby assisting in the sulfate dissociation and advancing the catalysis (Negishi et al., 2001; Yoshinari et al., 200…”
InfluentialVrbanac, J., & Slauter, R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803620-4.00003-7 · Cited by 77
Dawson, P. A. (2011) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2011.03.004 · Cited by 82
Mechanisms of tumor cell resistance to the current targeted-therapy agents
Khamisipour, G., Jadidi‐Niaragh, F., Jahromi, A. S., Zandi, K., & Hojjat‐Farsangi, M. (2016) · Tumor Biology · doi:10.1007/s13277-016-5059-1 · Cited by 79
Pharmacometabonomics and personalized medicine
Everett, J. R., Loo, R. L., & Pullen, F. S. (2013) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563213497929 · Cited by 75
The Role of CYP450 Drug Metabolism in Precision Cardio-Oncology
Fatunde, O. A., & Brown, S.-A. N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020604 · Cited by 77
Kim, S., Ga, S., Bae, H., Sluyter, R., Konstantinov, K., Shrestha, L. K., Kim, J. H., Kim, J. H., & Ariga, K. (2023) · EES Catalysis · doi:10.1039/d3ey00239j · Cited by 75
Secky, L., Svoboda, M., Klameth, L., Bajna, E., Hamilton, G., Zeillinger, R., Jäger, W. R., & Thalhammer, T. (2013) · Journal of Drug Delivery · doi:10.1155/2013/957605 · Cited by 75
“3-phosphoadenosine 5-phosphosulfate synthase (PAPSS) catalyzes the biosynthesis of PAPS, which serves as the sulfate donor (see [22]).”
BackgroundSulfur metabolism and its contribution to malignancy
Ward, N. P., & DeNicola, G. M. (2019) · International review of cytology · doi:10.1016/bs.ircmb.2019.05.001 · Cited by 82
Liang, G., Man, Y., Jin, X., Pan, L., & Liu, X. (2016) · Analytica Chimica Acta · doi:10.1016/j.aca.2016.06.056 · Cited by 74
Analysis and measurement of serotonin
Szeitz, A. J., & Bandiera, S. M. (2017) · Biomedical Chromatography · doi:10.1002/bmc.4135 · Cited by 75
The role of biotransformation and bioactivation in toxicity
Dekant, W. (2009) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-7643-8336-7_3 · Cited by 72
Effects of Bacterial Colonization on the Porcine Intestinal Proteome
Danielsen, M., Hornshøj, H., Siggers, R. H., Jensen, B. B., Kessel, A. G. V., & Bendixen, E. (2007) · Journal of Proteome Research · doi:10.1021/pr070038b · Cited by 72
Autoinhibitory sterol sulfates mediate programmed cell death in a bloom-forming marine diatom
Gallo, C., d’Ippolito, G., Nuzzo, G., Sardo, A., & Fontana, A. (2017) · Nature Communications · doi:10.1038/s41467-017-01300-1 · Cited by 75
Tibbs, Z. E., Rohn‐Glowacki, K. J., Crittenden, F., Guidry, A. L., & Falany, C. N. (2014) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2014.10.004 · Cited by 73
Recent advances in sulfotransferase enzyme activity assays
Paul, P., Suwan, J., Liu, J., Dordick, J. S., & Linhardt, R. J. (2012) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-012-5944-4 · Cited by 71
“Sulfo group transfer is an important reaction in the chemical metabolism of drugs, chemical carcinogens, hormones, bile acids, neurotransmitters, peptides, and lipids [7].”
Metadata
- Authors
- Gamage, N., Barnett, A., Hempel, N., Duggleby, R. G., Windmill, K. F., Martin, J. L., & McManus, M. E.
- Affiliations
- The University of Queensland (AU)
- Corresponding author
- Gamage, Niranjali
- Venue
- Toxicological Sciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-12-01
- Volume
- 90
- Issue
- 1
- Pages
- 5-22
- ISSN
- 1096-0929 (ISSN-L)
- 1096-6080
- OpenAlex
- W2167832449
- Cited by
- 703
- References
- 90
- Citations by year
- 2026: 26 · 2025: 37 · 2024: 33 · 2023: 37 · 2022: 40 · 2021: 47 · 2020: 35 · 2019: 34 · 2018: 32 · 2017: 41 · 2016: 40 · 2015: 36 · 2014: 41 · 2013: 44 · 2012: 31
- FWCI
- 2.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Toxicological Sciences (publishedVersion)
- PubMed (publishedVersion)
- Griffith Research Online (submittedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glutathione Transferases and Polymorphisms
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- sulfotransferase, sulfonation, xenobiotic metabolism, drug metabolism, procarcinogen activation, detoxification enzymes, fetal development, enzyme substrate specificity, enzyme kinetics, enzyme inhibition, transcriptional regulation, interindividual variability, genetic polymorphism, disease susceptibility
- MeSH terms
- Animals, Biotransformation, Crystallization, Humans, Isoenzymes, Models, Molecular, Protein Conformation, Sulfotransferases, Xenobiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.